United States
Pharmaceutical pipeline strategist with MAcc, MBA, PharmD. Work experience in commercial and managed care operations, market research, strategy analysis, and competitive intelligence. Well-developed research, analytical, and reporting skills. Background includes conducting primary and secondary market research, identifying key barriers to market access, and preparing business strategies to optimize internal objectives. Direct clinical and treatment pathway experience through site-directed education and affiliation participation. Payer, healthcare provider, and market insight through professional work experience.
Served as business insights lead for early stage clinical programs and desk research lead for nondisclosed exploratory indications and across portfolio. Competitive intelligence co-lead with medical affairs team. Selected Accomplishments: * Created opportunity assessments with market development lead for three early pipeline indications consisting of disease background, epidemiology, treatment landscape, pipeline competitors, and forecasted revenue. * Generated insights to refine market understanding in Japan, including HCP perceptions, patient journey, and market access and pricing opportunities. * Built and standardized market insights book to create single source of truth across organization with quarterly updates. * Developed framework for ‘Rapid Response Team’ to complete in-depth label analysis and identify limitations of competitor label approval. Analysis delivered within 12 hours of regulatory approval.
Completed 15+ engagements in several markets (US, EU5, JP, CAN) to provide strategic commercial direction for pipeline candidates in early- to late-stage development and post-launch assets across multiple disease states including rare diseases, immunology, neurology, and oncology Selected Accomplishments: Market Access and Pricing Strategy * Led 100+ interviews with multiple payer stakeholders (US health insurers/PBMs/Hospital P&T; UK NICE/CCGs/Trusts; DE IQWiG/G-BA/GKV; FR HAS/CEPS; IT AIFA/Regional MoH; ES Regional Agencies/Hospital P&T). * Proposed strategy to establish a risk-shared agreement with EU regional and local payer stakeholders. * Utilized multiple pricing methods (i.e., conjoint analysis, Gabor-Granger, and Van Westendorp) to identify pricing corridors and access limitations. Cross-functional & Client Stakeholder Management * Project lead for large-scale analysis across 28 developed and emerging markets to identify PRMA challenges and track access management / changes in pricing landscape; developed centralized avenue to prioritize urgency of requested support to eliminate barriers and achieve local goals. * Presented global market access perspective for key business partners from business development, marketing, commercial, and medical. * Provided updates to clients on emerging payer trends including US’ payers outlook on outcomes-based contracting and expectations of Japan’s soon-to-be HTA requirements.
Analyzed top providers in the immunology fields to calculate metric goals for successful prior authorization approval and appeal rates, based on the numbers and reasons for each specific medication, per physician. Aso provided field support and delivered information on physicians, presentations, and more for field teams. Selected Accomplishments: * Developed metrics to improve the marketing of products based on prior authorization rates. * Designed a market access strategy implemented by the company for 2 specialty products, outlining competitive plans and targets. * Facilitated an increase in sales and brand visibility by establishing ideal patient profiles based on insurance provider and past therapies, to improve prior authorization status.